NCT02281422View on ClinicalTrials.gov

An Open-label, Single-dose, Single-centre Study, Investigating the Pharmacokinetics of BIA 2-093

PHASE1CompletedINTERVENTIONAL
Enrollment

40

Participants

Timeline

Start Date

March 31, 2005

Primary Completion Date

June 30, 2006

Study Completion Date

June 30, 2006

Conditions
Epilepsy
Interventions
DRUG

BIA 2-093

Trial Locations (1)

9301

Farmovs-Parexel, Bloemfontein

All Listed Sponsors
lead

Bial - Portela C S.A.

INDUSTRY

NCT02281422 - An Open-label, Single-dose, Single-centre Study, Investigating the Pharmacokinetics of BIA 2-093 | Biotech Hunter | Biotech Hunter